FDA Approvals

According to a report by the Indian industry group CII, there is a need to expedite regulatory processes and eliminate...

Daiichi Sankyo, a Japanese company, has been concentrating on a series of antibody-drug conjugates, but it has achieved a world...

Despite the fact that the decision to severely restrict coverage of an expensive new Alzheimer's medicine, U.S. President Joe Biden...

The Critical Path for Rare Neurodegenerative Diseases (CP-RND), a new public-private partnership created to advance the development of treatments for...

The fixed-dose combination Opdualag (nivolumab and relatlimab) from Bristol Myers Squibb (BMS) has received clearance from the European Commission for...

Australia has authorised the use of a new targeted therapy for the treatment of cholangiocarcinoma, a rare bile duct cancer....

Beyfortus has received approval from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency to...

Upcoming gene therapies may be the most economical option for people with haemophilia types A and B to address their...

Dupixent, the immunology favourite developed by Sanofi and Regeneron Pharmaceuticals, is still on the rise. It has received back-to-back approvals...

A group of Food and Drug Administration advisers has recently come out in favour of a carefully monitored ALS drug,...